We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Diagnostic Value of HS-CRP in Stable Angina.

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00719992
First Posted: July 22, 2008
Last Update Posted: July 22, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Shiraz University of Medical Sciences
July 18, 2008
July 22, 2008
July 22, 2008
April 2006
August 2007   (Final data collection date for primary outcome measure)
significant coronary lesion
Same as current
No Changes Posted
severity of CAD
Same as current
Not Provided
Not Provided
 
Diagnostic Value of HS-CRP in Stable Angina.
Diagnostic Value of HS-CRP in Stable Angina Patients With Positive Exercise Test as Compared With Coronary Angiography.
The aim of this study was to assess the amount of additive value of HS-CRP levels to a positive exercise tolerance test (ETT) in predicting coronary artery disease (CAD) using coronary angiography as the gold standard. The investigators concluded that HS-CRP can be used as a single predictor of coronary vessel involvement in patients with stable angina and positive ETT.
the investigators included 97 patients with positive ETT and stable angina and saw that Hs-CRP is the only predictor of severity of CAD as compared with coronary angiography in stable angina patients.
Interventional
Not Provided
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Diagnostic
  • Stable Angina
  • Positive ETT
Procedure: coronary angiography
effect of level of HS-CRP
  • Experimental: 1
    positive ETT, High HS-CRP
    Intervention: Procedure: coronary angiography
  • Active Comparator: 2
    positive ETT, Low HS-CRP
    Intervention: Procedure: coronary angiography
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
97
August 2007
August 2007   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Stable angina
  • Positive ETT

Exclusion Criteria:

  • Unability to perform ETT
  • Contraindications for ETT and angiography study
Sexes Eligible for Study: All
43 Years to 64 Years   (Adult)
No
Contact information is only displayed when the study is recruiting subjects
Iran, Islamic Republic of
 
 
NCT00719992
4543
Yes
Not Provided
Not Provided
Dr Javad Kojuri, Shiraz University of medical sciences
Shiraz University of Medical Sciences
Not Provided
Study Director: javad kojuri, M.D. Shiraz University of Medical Sciences
Shiraz University of Medical Sciences
July 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP